Our laboratory investigates the regulatory mechanisms underlying tumor-specific CD8 T cell dysfunction in the context of solid tumors. Cancer cells express mutated proteins that are distinct from the proteins in normal cells. These are known as tumor-specific antigens. Over a century ago, scientists reasoned that our immune system should be able to recognize these mutated proteins as foreign and eliminate cancer cells. However, although tumor-specific T cells are found within human tumors, they are not functional and allow cancers to grow unimpeded.

Visit our lab website

Learn more
The Andrea Schietinger Lab

Andrea Schietinger, PhD

Assistant Professor

Research Focus

Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.


PharmD, University of Hamburg, PhD, University of Chicago, Chicago, IL and University of Munich, Germany

Lab Members

Career Opportunities

Learn more